The centrality of the patient is an increasingly relevant and topical issue and, for IBSA, it’s a critical aspect of its philosophy, closely linked to the Quality pillar. Quality is an essential and integral part of the company culture and is to be found in all corporate processes and in every step of our products’ life cycle. In the words of Andreas Gerber, Chief Quality Officer at IBSA: “Quality is in our DNA”. A statement that reflects the very essence of the company: quality is an added value, not a simple regulatory obligation.
IBSA stories
IBSA quality as a pillar for patients, for the future
A CULTURE OF SHARED QUALITY
In an increasingly complex global market, maintaining high quality standards is the challenge, a challenge that represents a great opportunity. Indeed, IBSA works every day to promote a culture of quality that involves every single collaborator, since this is not a “duty” limited to the QA (Quality Assurance) and QC (Quality Control) departments only.
Whether it is Research and Development, Production or Logistics, Marketing or Communication, each department is called upon to pursue the shared objectives of ensuring that products are safe and effective and contributing to the good reputation of the company.
The importance of a long-term vision in quality management, explained Gerber, is the key to the challenge: “It’s not just about maintaining high standards, but anticipating the challenges of the future. Quality, for us, is also innovation: we work to constantly improve our processes, making them more efficient and sustainable”.
A “GLOBAL” QUALITY
This perspective oriented towards continuous improvement is clearly visible in IBSA’s commitment to adopting innovative technologies and methodologies, always with an eye to the future. “It is crucial to think today about what tomorrow will be like, because quality must be continuously nourished; it’s dynamic, it’s constantly evolving”, continued Gerber.
Precisely for this reason, from July 1, 2024, IBSA combined the Quality Assurance and Quality Control functions into a single “Quality” area, under the leadership of Andreas Gerber. This reorganisation aims to optimise processes, improve communication and create synergy between departments, so as to guarantee a unified approach to quality, for the benefit of the safety and effectiveness of the products, and therefore of patients.
This is an approach that also gives added value in the way IBSA interfaces with its various subsidiaries: in addition to defining the guidelines, it is in fact necessary to listen and interpret the needs of the various markets, ensuring that the standards are shared internationally.
Global quality strategies, so organically harmonised, are the basis for the growth of safety standards.
